The total return over the past 12 months is -1.44% vs. +16.94% for the S&P 500. So far it's up -14.54% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (1.44%) | (5.65%) | (22.38%) | +8.90% | N/A | N/A |
| Total Return CAGR | (1.44%) | (5.65%) | (22.38%) | +8.90% | N/A | N/A |
| Revenue CAGR | +6.83% | +1.76% | (18.66%) | +37.71% | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Fulgent Genetics, Inc. (FLGT)
| Year | Start price | End price | FLGT Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $26.27 | $22.45 | (14.54%) | +14.51% | (29.05%) |
| 2025 | $18.47 | $26.27 | +42.23% | +17.72% | +24.51% |
| 2024 | $28.91 | $18.47 | (36.11%) | +24.89% | (61.00%) |
| 2023 | $29.78 | $28.91 | (2.92%) | +26.19% | (29.11%) |
| 2022 | $100.59 | $29.78 | (70.39%) | (18.17%) | (52.22%) |
| 2021 | $52.10 | $100.59 | +93.07% | +28.74% | +64.33% |
| 2020 | $12.90 | $52.10 | +303.88% | +18.37% | +285.51% |
| 2019 | $3.17 | $12.90 | +306.94% | +31.22% | +275.72% |
| 2018 | $4.38 | $3.17 | (27.63%) | (4.56%) | (23.07%) |
| 2017 | $11.57 | $4.38 | (62.14%) | +21.70% | (83.84%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
